Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 11, 2017Antimicrobial Agents and ChemotherapyOpen Access

Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy

View Full Paper
Ask AI
Bookmark
Share

Authors

MZMatthew ZimmermanUniversity of Minnesota Medical CenterJLJodi M. LestnerUniversity of LiverpoolBPBrendan PrideauxHackensack Meridian Health

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zimmerman et al. (2017) studied this question.

synapsesocial.com/papers/69ffda8f7ac91c5d2a2d63adhttps://doi.org/10.1128/aac.00924-17
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prediction of Drug Penetration in Tuberculosis Lesions2016 · 152 citations
  2. 2Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis2014 · 666 citations
  3. 3Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug2004 · 235 citations
  4. 4Impact of food on the pharmacokinetics of first-line anti-TB drugs in treatment-naive TB patients: a randomized cross-over trial2015 · 62 citations
  5. 5The early bactericidal activity of drugs in patients with pulmonary tuberculosis.1980 · 498 citations